About Klaus Veitinger
Klaus Veitinger is a director at Sparrow Pharmaceuticals.
Form D filings also name Klaus Veitinger as an executive chairman of the board at Alpheus Medical.
Klaus Veitinger reports to the SEC as a director of 4 public companies, including scPharmaceuticals (SCPH), Tricida (TCDA) and Intercept Pharmaceuticals (ICPT).
Klaus Veitinger first appears on SEC filings in 2012.
Experience
This experience comes from Klaus Veitinger's profile and from SEC filings. For roles taken from filings, the years are when the filings name Klaus Veitinger in the role, so the role may have started earlier or lasted longer.
HB
Helicore Biopharma Current
Executive Chairman
2024 – Present
CD
Cure Rare Disease Current
Board Member
2024 – Present
FR
FDA - Brain Cancer Research Roundtable Current
Investor Representative
2021 – Present
Alpheus Medical, Inc. Current
Executive Chairman of the Board
2020 – Present · Chanhassen, MN
Develops an investigational drug and ultrasound therapy for people with glioblastoma.
AT
Alliance for Cancer Gene Therapy Current
Board Member
2020 – Present
OR
OrbiMed Current
Venture Partner
2007 – Present
SI
scPharmaceuticals Inc.
Director
2017 – 2025 · Public company (SCPH)
NI
Neurogastrx, Inc.
Chairman of the Board
2017 – 2025
TI
Tricida, Inc.
Chairman of the Board
2013 – 2023 · Public company (TCDA)
SL
Symbiomix Therapeutics, LLC
CEO
2014 – 2017
II
Intercept Pharmaceuticals, Inc.
Director
2012 – 2016 · Public company (ICPT)
RI
Relypsa Inc
Vice Chairman of the Board
2010 – 2015 · Public company (RLYP)
SC
Synageva BioPharma Corp.
Board Member
2007 – 2008
AN
AnorMED
Vice Chairman of the Board
2006
SI
Schwarz Pharma Inc.
CEO
1998 – 2006
Key Colleagues at Startups
The people Klaus Veitinger works with at each company, as listed on that company's latest Form D.
Alpheus Medical, Inc. · Form D/A, Jul 30, 2026
Jeremy Ling
Chief Technology Officer
RS
Robert Stein
Director
Vijay Agarwal
Founder, President and CEO, director
JJ
John Johnson
Director
PT
Peter Thompson
Director
IE
Imran Eba
Chief Financial Officer
SW
Steve Weiner
Executive officer
JM
Juan-Pablo Mas
Director
Sparrow Pharmaceuticals, Inc. · Form D, Jul 1, 2025
JR
Jonathan Root
Director
ND
Niall O'Donnell
Director
ZS
Zach Scheiner
Director
NN
Nanna L?neborg
Director
PT
Peter Thompson
Director
RJ
Robert Jacks
Chief Executive Officer and director